Mohaned Adil
Impact in
-
- Hydrogels: synthesis, properties, applications
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Circular RNAs in diseases 13
- Extracellular vesicles in disease 8
- Gut microbiota and health 4
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 8
- Co-authors
- Mohamed J. Saadh (16 shared papers)Fahad Alsaikhan (7 shared papers)Mahmood Jasem Jawad (7 shared papers)Bagher Farhood (8 shared papers)Rahman S. Zabibah (6 shared papers)Asghar Narmani (3 shared papers)Mohammed Shnain Ali (4 shared papers)Chou‐Yi Hsu (4 shared papers)
In The Last Decade
Mohaned Adil
52 papers receiving 308 citations
Peers
Comparison fields: 5 of 89
- Molecular Medicine 25
- Biomaterials 48
- Pharmaceutical Science 20
- Cancer Research 20
- Molecular Biology 91
Countries citing papers authored by Mohaned Adil
This map shows the geographic impact of Mohaned Adil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohaned Adil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohaned Adil more than expected).
Fields of papers citing papers by Mohaned Adil
This network shows the impact of papers produced by Mohaned Adil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohaned Adil. The network helps show where Mohaned Adil may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohaned Adil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 41 | |
| 2 | 2024 | 32 | |
| 3 | 2024 | 19 | |
| 4 | 2023 | 17 | |
| 5 | 2024 | 16 | |
| 6 | 2025 | 12 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 9 | |
| 11 | 2024 | 9 | |
| 12 | 2023 | 8 | |
| 13 | 2023 | 8 | |
| 14 | 2024 | 7 | |
| 15 | 2025 | 7 | |
| 16 | 2024 | 7 | |
| 17 | 2023 | 7 | |
| 18 | 2023 | 5 | |
| 19 | 2025 | 5 | |
| 20 | 2025 | 4 |
About Mohaned Adil
Mohaned Adil is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Epidemiology, having authored 74 papers that have together received 313 indexed citations. Recurring topics across this work include Circular RNAs in diseases (13 papers), Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers), Extracellular vesicles in disease (8 papers), Hepatitis B Virus Studies (4 papers), Gut microbiota and health (4 papers), Boron and Carbon Nanomaterials Research (4 papers) and Graphene and Nanomaterials Applications (4 papers). The work is most often cited by research in Molecular Medicine (25 citations), Biomaterials (48 citations), Pharmaceutical Science (20 citations), Cancer Research (20 citations) and Molecular Biology (91 citations). Mohaned Adil has collaborated with scholars based in Iraq, India and Jordan. Frequent co-authors include Mohamed J. Saadh, Fahad Alsaikhan, Mahmood Jasem Jawad, Bagher Farhood, Rahman S. Zabibah, Asghar Narmani, Mohammed Shnain Ali, Chou‐Yi Hsu, Saman Yasamineh and Mohammed Ahmed Mustafa. Their work appears in journals such as Medical Oncology, Clinica Chimica Acta, Gene, International Immunopharmacology and Virology Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.